Nonmyeloablative Allogeneic Stem-Cell Transplantation for Metastatic Renal Cell Cancer: A Review and Update
Metastatic renal cell carcinoma (RCC) is resistant to conventional chemotherapy and radiotherapy. However, immunotherapy appears to be effective in 15—20% of cases, with interleukin-2 becoming the standard therapy for this disease. As a consequence of the immune susceptibility of RCC, other avenues...
Saved in:
| Main Authors: | P. Erotocritou, H. Ahmed, S.S. Patel, I. Shergill, H.R. Patel, P.M. Shah, M. Arya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2006.391 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
by: Maxim Yankelevich, et al.
Published: (2017-01-01) -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01) -
Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01) -
Four cases of renal injury associated with allogeneic haematopoietic stem cell transplantation and literature review
by: Dong Ze-xuan, et al.
Published: (2025-01-01) -
Four cases of renal injury associated with allogeneic haematopoietic stem cell transplantation and literature review
by: Dong Ze-xuan, et al.
Published: (2025-01-01)